Finance

Lists
Why is CNBX up 11,11%?
Dive Deeper
CNBX:OTCMKTS
CNBX Pharmaceuticals Inc
USD 0,00015
+11,11%
(+0,000015) 1D
16 Okt., 16:00:00 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for CNBX...
Open
USD 0,00
High
USD 0,00
Low
USD 0,00
Mkt. cap
333,60
Avg. vol.
6,06 m
Volume
6,50 m
52-wk high
USD 0,00
52-wk low
USD 0,00
EPS
-USD 0,00
Beta
-2,39
Shares outstanding
1,61 mjd
No. of employees
1
Open
USD 0,00
High
USD 0,00
Low
USD 0,00
Mkt. cap
333,60
Avg. vol.
6,06 m
Volume
6,50 m
52-wk high
USD 0,00
52-wk low
USD 0,00
EPS
-USD 0,00
Beta
-2,39
Shares outstanding
1,61 mjd
No. of employees
1
News stories
From web sources and news partners
About CNBX Pharmaceuticals Inc
CEO-
Employees1
Founded2004
Headquarters-
SectorPharmaceutical industry
Websitecnbxpharma.com
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Aug. 2025
Nov. 2025
Feb. 2026
Mei 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
129,73 k
64,00 k
72,96 k
162,76 k
Operating expense
129,73 k
64,00 k
72,96 k
162,76 k
Total operating expenses
129,73 k
64,00 k
72,96 k
162,76 k
Operating income
-129,73 k
-64,00 k
-72,96 k
-162,76 k
Other non operating income
-
-
-
-
EBT including unusual items
-150,11 k
-113,72 k
-44,10 k
-154,16 k
EBT excluding unusual items
-150,11 k
-113,72 k
-44,10 k
-154,16 k
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-150,11 k
-113,72 k
-44,10 k
-154,16 k
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
-
-
28,86 k
8,60 k
Interest expense
-18,28 k
-49,72 k
-
-
Net interest expenses
-18,28 k
-49,72 k
28,86 k
8,60 k
Depreciation and amortization charges
-
-
-
-
EBITDA
-111,65 k
-
-
-
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google-programme